Longitudinal analysis of tetanus- and influenza-specific IGG antibodies in myeloma patients

Clinical and Developmental Immunology

Volumn 2012, Issue , 2012, Pages

  Kobold, Sebastian ^a,b   Luetkens, Tim ^a   Bartels, Britta Marlen ^a   Cao, Yanran ^a   Hildebrandt, York ^a   Sezer, Orhan ^a   Reinhard, Henrike ^a   Templin, Julia ^a   Bartels, Katrin ^a   Lajmi, Nesrine ^a   Haag, Friedrich ^a   Bokemeyer, Carsten ^a   Kröger, Nicolaus ^a   Atanackovic, Djordje ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY; TETANUS TOXOID; ANTINEOPLASTIC AGENT; BACTERIUM ANTIBODY; CORE PROTEIN; IMMUNOGLOBULIN G; NP PROTEIN, INFLUENZA A VIRUS; RNA BINDING PROTEIN; VIRUS ANTIBODY;

ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; IMMUNOREACTIVITY; IMMUNOSUPPRESSIVE TREATMENT; INFLUENZA VIRUS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; PRIORITY JOURNAL; AGED; ALLOTRANSPLANTATION; B LYMPHOCYTE; BIOSYNTHESIS; BLOOD; CASE CONTROL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMORAL IMMUNITY; IMMUNOLOGY; INFLUENZA VIRUS A; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; STEM CELL TRANSPLANTATION;

AGED; ANTIBODIES, BACTERIAL; ANTIBODIES, VIRAL; ANTINEOPLASTIC AGENTS; B-LYMPHOCYTES; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNITY, HUMORAL; IMMUNOGLOBULIN G; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSION; INFLUENZAVIRUS A; INJECTIONS, INTRAVENOUS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIPLE MYELOMA; RNA-BINDING PROTEINS; STEM CELL TRANSPLANTATION; TETANUS TOXOID; TRANSPLANTATION, HOMOLOGOUS; VIRAL CORE PROTEINS;

EID: 84859706276     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2012/134081     Document Type: Article

References (28)

1. Palumbo A., Anderson K., Multiple myeloma The New England Journal of Medicine 2011 364 11 1046 1060
2. Cao Y., Luetkens T., Kobold S., Hildebrandt Y., Gordic M., Lajmi N., Meyer S., Bartels K., Zander A. R., Bokemeyer C., Krger N., Atanackovic D., The cytokine/chemokine pattern in the bone marrow environment of multiple myeloma patients Experimental Hematology 2010 38 10 860 867
3. Munshi N. C., Immunoregulatory mechanisms in multiple myeloma Hematology/Oncology Clinics of North America 1997 11 1 51 69 (Pubitemid 27147746)
4. Trono D., Kapanci Y., Causes of death in cases of lymphoma, myeloma and Hodgkin disease. Study of 218 cases Schweizerische Medizinische Wochenschrift 1983 113 19 701 708 (Pubitemid 13091388)
5. Raanani P., Gafter-Gvili A., Paul M., Ben-Bassat I., Leibovici L., Shpilberg O., Immunoglobulin prophylaxis in hematological malignancies and hematopoietic stem cell transplantation Cochrane Database of Systematic Reviews 2008 4 CD006501
6. Lokhorst H., Einsele H., Vesole D., Bruno B., San Miguel J., Perez-Simon J. A., Kroger N., Moreau P., Gahrton G., Gasparetto C., Giralt S., Bensinger W., International myeloma working group consensus statement regarding the current status of allogeneic stem-cell transplantation for multiple myeloma Journal of Clinical Oncology 2010 28 29 4521 4530
7. Kroger N., Unrelated stem cell transplantation for patients with multiple myeloma Current Opinion in Hematology 2010 17 6 538 543
8. Ek T., Mellander L., Hahn-Zoric M., Abrahamsson J., Avidity of Tetanus and Hib antibodies after childhood acute lymphoblastic leukaemiaimplications for vaccination strategies Acta Paediatrica 2006 95 6 701 706 (Pubitemid 43879564)
9. van Tilburg C. M., Sanders E. A. M., Rovers M. M., Wolfs T. F. W., Bierings M. B., Loss of antibodies and response to (re-)vaccination in children after treatment for acute lymphocytic leukemia: a systematic review Leukemia 2006 20 10 1717 1722 (Pubitemid 44574983)
10. Nordy T., Husebekk A., Aaberge I. S., Jenum P. A., Samdal H. H., Flugsrud L. B., Kristoffersen A. C., Holte H., Kvaly S., Kolstad A., Humoral immunity to viral and bacterial antigens in lymphoma patients 4-10 years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelines Bone Marrow Transplantation 2001 28 7 681 687 (Pubitemid 33014602)
11. Issa N. C., Marty F. M., Gagne L. S., Koo S., Verrill K. A., Alyea E. P., Cutler C. S., Koreth J., Armand P., Ho V. T., Antin J. H., Soiffer R. J., Baden L. R., Seroprotective Titers against 2009 H1N1 Influenza A Virus after Vaccination in Allogeneic Hematopoietic Stem Cell Transplantation Recipients Biology of Blood and Marrow Transplantation 2010
12. Atanackovic A. D., Luetkens T., Hildebrandt Y., Arfsten J., Bartels K., Horn C., Stahl T., Cao Y., Zander A. R., Bokemeyer C., Krger N., Longitudinal analysis and prognostic effect of cancer-testis antigen expression in multiple myeloma Clinical Cancer Research 2009 15 4 1343 1352
13. Kobold S., Tams S., Luetkens T., Cao Y., Sezer O., Bartels B. M., Reinhard H., Templin J., Bartels K., Hildebrandt Y., Lajmi N., Marx A., Haag F., Bokemeyer C., Krger N., Atanackovic D., Patients with multiple myeloma develop SOX2-specific autoantibodies after allogeneic stem cell transplantation Clinical and Developmental Immunology 2011 2011 10
14. Bland J. M., Altman D. G., Calculating correlation coefficients with repeated observations: part 2correlation between subjects British Medical Journal 1995 310 6980 633
15. Bland J. M., Altman D. G., Calculating correlation coefficients with repeated observations: part Icorrelation within subjects British Medical Journal 1995 310 6977 446
16. Pilarski L. M., Ruether B. A., Mant M. J., Abnormal function of B lymphocytes from peripheral blood of multiple myeloma patients. Lack of correlation between the number of cells potentially able to secrete immunoglobulin M and serum immunoglobulin M levels Journal of Clinical Investigation 1985 75 6 2024 2029 (Pubitemid 15233593)
17. Harris J., Alexanian R., Hersh E., Migliore P., Immune function in multiple myeloma: impaired responsiveness to keyhole limpet hemocyanin Canadian Medical Association Journal 1971 104 5 389 393
18. Robertson J. D., Nagesh K., Jowitt S. N., Dougal M., Anderson H., Mutton K., Zambon M., Scarffe J. H., Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma British Journal of Cancer 2000 82 7 1261 1265 (Pubitemid 30145342)
19. Maecker B., Anderson K. S., Von Bergwelt-Baildon M. S., Weller E., Vonderheide R. H., Richardson P. G., Schlossman R. L., Menezes I. A., Xia Z., Munshi N. C., Anderson K. C., Nadler L. M., Schultze J. L., Viral antigen-specific CD8+ T-cell responses are impaired in multiple myeloma British Journal of Haematology 2003 121 6 842 848 (Pubitemid 36760302)
20. Birgens H. S., Espersen F., Hertz J. B., Antibody response to pneumococcal vaccination in patients with myelomatosis Scandinavian Journal of Haematology 1983 30 4 324 330 (Pubitemid 13113846)
21. Rapezzi D., Sticchi L., Racchi O., Mangerini R., Ferraris A. M., Gaetani G. F., Influenza vaccine in chronic lymphoproliferative disorders and multiple myeloma European Journal of Haematology 2003 70 4 225 230 (Pubitemid 36469759)
22. Ilan Y., Nagler A., Zeira E., Adler R., Slavin S., Shouval D., Maintenance of immune memory to the hepatitis B envelope protein following adoptive transfer of immunity in bone marrow transplant recipients Bone Marrow Transplantation 2000 26 6 633 638
23. Garland P., de Lavallade H., Sekine T., Hoschler K., Sriskandan S., Patel P., Brett S., Stringaris K., Loucaides E., Howe K., Marin D., Kanfer E., Cooper N., Macdonald D., Rahemtulla A., Atkins M., Danga A., Milojkovic D., Gabriel I., Khoder A., Alsuliman A., Apperley J., Rezvani K., Humoral and Cellular Immunity to Primary H1N1 Infection in Patients with Hematologic Malignancies following Stem Cell Transplantation Biology of Blood and Marrow Transplantation 2010
24. Mohty B., Bel M., Vukicevic M., Nagy M., Levrat E., Meier S., Grillet S., Combescure C., Kaiser L., Chalandon Y., Passweg J., Siegrist C.-A., Roosnek E., Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients Haematologica 2011 96 6 896 904
25. Gerritsen E. J. A., Van Tol M. J. D., Van 't Veer M. B., Wels J. M. A., Khouw I. M. S. L., Touw C. R., Jol-Van der Zijde C. M., Hermans J., Rumke H. C., Radl J., Vossen J. M., Clonal dysregulation of the antibody response to tetanus-toxoid after bone marrow transplantation Blood 1994 84 12 4374 4382 (Pubitemid 24371945)
26. Raanani P., Gafter-Gvili A., Paul M., Ben-Bassat I., Leibovici L., Shpilberg O., Immunoglobulin prophylaxis in hematopoietic stem cell transplantation: systematic review and meta-analysis Journal of Clinical Oncology 2009 27 5 770 781
27. Vrdoljak A., Trescec A., Benko B., Simic M., A microassay for measurement of Fc function of human immunoglobulin preparations by using tetanus toxoid as antigen Biologicals 2004 32 2 78 83 (Pubitemid 39348756)
28. Amanna I. J., Carlson N. E., Slifka M. K., Duration of humoral immunity to common viral and vaccine antigens New England Journal of Medicine 2007 357 19 1903 1915 (Pubitemid 350074686)